Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Colorectal Cancer Metastatic × LY-2157299 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Glioma 1 Glioblastoma 1 Colorectal Cancer Metastatic 1

Interventions

Capecitabine 6 Bevacizumab 5 trifluridine tipiracil drug combination 3 Cetuximab 3 Oxaliplatin 2 sintilimab 1 monoclonal antibody YYB-101 1 aflibercept 1 Vemurafenib 1 Nivolumab 1 LY-2157299 1 Irinotecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03470350 2019-07-24

EORTC1615

The Netherlands Cancer Institute

Phase 1/2 Withdrawn

Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡